This report describes the global market size of Biopharmaceutical CMO & CRO from 2018 to 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028.
For the geography segment, regional supply, demand, major players, price is presented from 2018 to 2028.
For the competitor segment, the report includes global key players of Biopharmaceutical CMO & CRO as well as some small players.
Historical Data: from 2018 to 2022
Forecast Data: from 2023 to 2028
This product will be delivered within 1-3 business days.
For the geography segment, regional supply, demand, major players, price is presented from 2018 to 2028.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes global key players of Biopharmaceutical CMO & CRO as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Applications Segment:
- Contract Manufacturing
- Contract Research
Types Segment:
- Biologics
- Biosimilars
Companies Covered:
- Lonza
- Boehringer Ingelheim GmbH
- Rentschler Biotechnologie GmbH
- Inno Biologics Sdn Bhd
- JRS Pharma (Celonic GmbH)
- BIOMEVA GmbH
- ProBioGen
- FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
- TOYOBO CO.
Historical Data: from 2018 to 2022
Forecast Data: from 2023 to 2028
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
Chapter Four Market Landscape
Chapter 5 Market Trend Analysis
Chapter 6 Industry Chain Analysis
Chapter 7 Latest Market Dynamics
Chapter 8 Historical and Forecast Biopharmaceutical Cmo & Cro Market in North America (2018-2028)
Chapter 9 Historical and Forecast Biopharmaceutical Cmo & Cro Market in South America (2018-2028)
Chapter 10 Historical and Forecast Biopharmaceutical Cmo & Cro Market in Asia & Pacific (2018-2028)
Chapter 11 Historical and Forecast Biopharmaceutical Cmo & Cro Market in Europe (2018-2028)
Chapter 12 Historical and Forecast Biopharmaceutical Cmo & Cro Market in MEA (2018-2028)
Chapter 13 Summary For Global Biopharmaceutical Cmo & Cro Market (2018-2023)
Chapter 14 Global Biopharmaceutical Cmo & Cro Market Forecast (2023-2028)
Chapter 15 Analysis of Global Key Vendors
Tables and Figures
Companies Mentioned
- Lonza
- Boehringer Ingelheim GmbH
- Rentschler Biotechnologie GmbH
- Inno Biologics Sdn Bhd
- JRS Pharma (Celonic GmbH)
- BIOMEVA GmbH
- ProBioGen
- FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
- TOYOBO CO.